Inter-organisational patent opposition network: How companies form adversarial relationships
Tomomi Kito, Nagi Moriya, Junichi Yamanoi

TL;DR
This study analyzes the structure and dynamics of inter-organisational patent opposition networks, revealing their unique topology, the coexistence of adversarial and collaborative relationships, and the mechanisms behind their formation.
Contribution
It is the first to examine inter-organisational adversarial patent relationships, uncovering their network properties and interaction with co-ownership, providing new insights into strategic patenting behavior.
Findings
The opposition network has a heavy-tailed, power-law degree distribution.
Many companies disapprove patents across sectors and borders.
Temporal motif analysis reveals imbalanced triadic structures.
Abstract
Much of the research on networks using patent data focuses on citations and the collaboration networks of inventors, hence regarding patents as a positive sign of invention. However, patenting is, most importantly, a strategic action used by companies to compete with each other. This study sheds light on inter-organisational adversarial relationships in patenting for the first time. We constructed and analysed the network of companies connected via patent opposition relationships that occurred between 1980 and 2018. A majority of the companies are directly or indirectly connected to each other and hence form the largest connected component. We found that in the network, many companies disapprove patents in various industrial sectors as well as those owned by foreign companies. The network exhibits heavy-tailed, power-law-like degree distribution and assortative mixing, making it an…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsIntellectual Property and Patents · CRISPR and Genetic Engineering · Computational Drug Discovery Methods
